Guru Ownership Trend
Guru Analysis for Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. (AMLX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.07 M.
Top institutional holders include Steven Cohen and Paul Tudor Jones.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $5.36 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 39.9%. Conversely, Steven Cohen reduced exposure by 68.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Amylyx Pharmaceuticals, Inc. (AMLX)
Major holders include Steven Cohen ($1.48 M), Paul Tudor Jones ($435,543), Cliff Asness ($404,338). According to the latest reported data, 3 tracked investment managers collectively hold approximately 166,958 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $5.36 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited AMLX. The total reported sell value was $5.5 M.
Yes, 0 managers opened new positions in AMLX, and 2 increased their existing holdings. The total reported buy value was $141,418.75.